Changing Treatment Paradigms for Brain Metastases From Melanoma—Part 2: When and How to Use the New Systemic Agents

In this article, we provide an overview of the currently available systemic agents, including immunotherapeutic agents and targeted tyrosine kinase inhibitors. We also provide a practical management algorithm to guide the practicing oncologist in the use of both of these new therapies and the more traditional local treatments.